Literature DB >> 10782554

Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning.

P L Morosini1, L Magliano, L Brambilla, S Ugolini, R Pioli.   

Abstract

OBJECTIVE: Development of a scale to assess patients' social functioning, the Personal and Social Performance scale (PSP).
METHOD: PSP has been developed through focus groups and reliability studies on the basis of the social functioning component of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS). The last reliability study was carried out by 39 workers with different professional roles on a sample of 61 psychiatric patients admitted to the rehabilitation unit. Each patient was rated independently on the scale by the two workers who knew them best.
RESULTS: The PSP is a 100-point single-item rating scale, subdivided into 10 equal intervals. The ratings are based mainly on the assessment of patient's functioning in four main areas: 1) socially useful activities; 2) personal and social relationships; 3) self-care; and 4) disturbing and aggressive behaviours. Operational criteria to rate the levels of disabilities have been defined for the above-mentioned areas. Excellent inter-rater reliability was also obtained in less educated workers.
CONCLUSION: Compared to SOFAS, PSP has better face validity and psychometric properties. It was found to be an acceptable, quick and valid measure of patients' personal and social functioning.

Entities:  

Mesh:

Year:  2000        PMID: 10782554

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  303 in total

1.  [PSP Scale: German version of the Personal and Social Performance Scale: valid instrument for the assessment of psychosocial functioning in the treatment of schizophrenia].

Authors:  D Schaub; G Juckel
Journal:  Nervenarzt       Date:  2011-09       Impact factor: 1.214

2.  An open-label, prospective study to evaluate social function and overall improvement of extended-release paliperidone treatment in Thai schizophrenia patients.

Authors:  Chawanun Charnsil; Salinee Vongpanich
Journal:  Neuropsychiatr Dis Treat       Date:  2013-08-20       Impact factor: 2.570

3.  Theta-Burst Transcranial Magnetic Stimulation for Posttraumatic Stress Disorder.

Authors:  Noah S Philip; Jennifer Barredo; Emily Aiken; Victoria Larson; Richard N Jones; M Tracie Shea; Benjamin D Greenberg; Mascha van 't Wout-Frank
Journal:  Am J Psychiatry       Date:  2019-06-24       Impact factor: 18.112

4.  Humour-related interventions for people with mental illness: a randomized controlled pilot study.

Authors:  Abraham Rudnick; Paul M Kohn; Kim R Edwards; David Podnar; Sara Caird; Rod Martin
Journal:  Community Ment Health J       Date:  2013-12-12

Review 5.  Brexpiprazole: so far so good.

Authors:  Saibal Das; Preeti Barnwal; Blessed Winston A; Somnath Mondal; Indranil Saha
Journal:  Ther Adv Psychopharmacol       Date:  2016-02

6.  Relationship Between Metabolic Syndrome and Clinical Features, and Its Personal-Social Performance in Patients with Schizophrenia.

Authors:  Omer Saatcioglu; Murat Kalkan; Nurhan Fistikci; Sakire Erek; Kasim Candas Kilic
Journal:  Psychiatr Q       Date:  2016-06

7.  Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder.

Authors:  Martha Sajatovic; Jennifer Levin; Luis F Ramirez; David Y Hahn; Curtis Tatsuoka; Christopher S Bialko; Kristin A Cassidy; Edna Fuentes-Casiano; Tiffany D Williams
Journal:  J Clin Psychiatry       Date:  2013-12       Impact factor: 4.384

8.  Importance of gender in the treatment of schizophrenia.

Authors:  Eva Ceskova; Radovan Prikryl
Journal:  Prim Care Companion CNS Disord       Date:  2012-11-15

9.  Patterns of care in patients discharged from acute psychiatric inpatient facilities: a national survey in Italy.

Authors:  Antonio Preti; Paola Rucci; Antonella Gigantesco; Giovanni Santone; Angelo Picardi; Rossella Miglio; Giovanni de Girolamo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-02-11       Impact factor: 4.328

10.  Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic.

Authors:  Pierre Chue
Journal:  Neuropsychiatr Dis Treat       Date:  2007-02       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.